Yangling, Shaanxi— (August 20, 2019)––Kiwa Bio-Tech Products Group Corp. (OTCQB: KWBT) (“Kiwa Bio-Tech” or “the Company”), an emerging agricultural company that develops, manufactures and markets bio-fertilizers for use in the multi-billion China agriculture and aquaculture markets is pleased to announce that the Company has reported financial results for the second quarter of 2019 ending June 30.
Second Quarter 2019 Results
- Revenue of $10,924,978 increased 105% compared to the same period in 2018.
Strategic development
- The Company completed research of a new fertilizer processing technology with the Institute of Bio-Agriculture of Shaanxi Academy of Sciences, the Research Center of Ultrasound Technology of Harbin University of Technology and the Environmental Group of Harbin University of Technology. The results of the research showed the solubility of solid fertilizers (including granules and powders) produced by traditional fertilizers in water has been increased by nearly 30% and this new process enables the granules of Kiwa’s fertilizer to reach nanometer fineness in drip system equipment and dissolve 100% in water, which will help Kiwa’s fertilizer products to be more widely used in agricultural market.
- The Company has signed a strategic agreement with Beijing Digital Cooperative Information Technology Limited. (DCIT). DCIT has developed a cooperative management system with big data as the core. This technology is effectively and perfectly combined with Kiwa’s Trinity Agricultural Marketing Model (Scientific Planting; Standardized Management; Industrialized Operation).
“Kiwa Bio-Tech’s second quarter performance laid a good foundation for the overall sales plan for 2019. At the same time, the cooperation between Kiwa and the local banks will be implemented in the third quarter. After incorporating financial support into Kiwa’s marketing process, it will enhance Company’s performance in our Trinity Agricultural Marketing Model and support the Company’s up-listing of our common stock from the OTC market,” stated Ms. Wang, Kiwa’s CEO.
Form 10-Q
For further information, please see the Company’s Quarterly Report on Form 10-Q at www.sec.gov, which the Company filed on August 19, 2019.
Kiwa Bio-Tech 2019 2Q Financial Report Link:
https://kiwabiotech.com/wp-content/uploads/2019/08/Kiwa-Bio-Tech-2019-2Q-Financial-Report.pdf
About Kiwa Bio-Tech Products Group Corp.
Leader in Eco-friendly Agricultural Industry Chain
Kiwa Bio-Tech Products Group Corp. (KWBT) is a publicly traded company with corporate headquarters in the Yangling, Shaanxi, China. The company develops, manufacture, markets and distributes innovative and environmentally safe bio-technological products for agriculture.Kiwa’s focus is to positively impact the environment by reducing the amount of chemical fertilizers that are being used by agricultural growers in China.
Kiwa Bio-Tech Products Group Corp. products are covered by patent protection and are designed to enhance the quality of human life by increasing the value and productivity of agricultural crops.
For more information on Kiwa Bio-Tech Products Group Corp. or its bio-fertilizer products and smart soil remediation technology, please refer to the Company’s website at www.kiwabiotech.com. or the Company filings with the United States Securities and Exchange Commission at www.sec.gov.
Forward-Looking Statements
This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company’s reports filed with the U.S. Securities and Exchange Commission. The forward-looking information provided herein represents the Company’s estimates as of the date of the press release, and subsequent events and developments may cause the Company’s estimates to change. The Company’s actual results may differ materially from those anticipated in the forward-looking statements depending on a number of risk factors including, but not limited to, the following: general economic, business and environment conditions, development, shipment, market acceptance, additional competition from existing and new competitors, changes in technology, the execution of its ten-year growth plan, the foreign exchange risk amid the unexpected announcements by the PRC government and various other factors beyond the Company’s control. Kiwa Bio-Tech Products Group Corp. specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company’s estimates of its future financial performance as of any date subsequent to the date of this press release.
Contact:
Kiwa Bio-Tech Products Group Corporation
ir@kiwabiotech.com
